From the Department of Pediatrics, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran
Abstract: (5543 Views)
We have used recombinant human erythropoietin (r-HuEPO) in children with
chronic renal failure. There was significant improvement in anemia and wellbeing,
along with regression of left ventricular mass and no change in the rate of
decline of renal function. It is safe and effective in the pre-dialysis as well as the
hemodialysis period. Considering the benefits of r-HuEPO, transplantation in
children can be postponed to a later time, when sufficient growth and development
have occurred, leading to better results of transplantation
Type of Study:
Original Research |
Subject:
Pediatric